1 / 52

COPD

COPD. Review. Progressive Syndrome Expiratory airflow obstruction Chronic airway and lung parenchyma inflammation. Preventable, treatable 24 million adults in US 4th leading cause of death in US: Heart disease Cancer Stroke COPD Accidents Diabetes.

korbin
Télécharger la présentation

COPD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. COPD Review

  2. Progressive • Syndrome • Expiratory airflow obstruction • Chronic airway and lung parenchyma inflammation

  3. Preventable, treatable • 24 million adults in US • 4th leading cause of death in US: • Heart disease • Cancer • Stroke • COPD • Accidents • Diabetes

  4. GOLD: global initiative for chronic obstructive lung diseasae • Expiratory airflow not fully reversible • Progressive, association with an “abnormal” lung response to noxious gases and particles

  5. Two major clinical types • Chronic bronchitis: inflammation of small and medium sized airways • Leads to expiratory defect, chronic cough, sputum production and dyspnea

  6. Emphysema • Inflammation of lung parenchyma • Loss of elastic recoil of lungs • Airflow limitation • Hypoxemia • dyspnea

  7. COPD • Irreversible airflow (as measured by FEV1 or FEV1/FVC) caused by: • Increased airway resistance in the conducting airways, or, • Increased lung compliance due to destruction of lung parenchyma/elasticity • Or a combination of both the above

  8. Chronic Bronchitis • Inflammation of the central airways (airways >4mm diameter and peripheral airways < 2 mm) • Extends to gland ducts and into the mucus producing glands • This produces increase mucus • Defective mucociliary clearance • Disruption (destruction) of epithelial barrier

  9. Airflow obstruction occurs primarily in the small airways which are <2mm diameter

  10. Emphysema • Decrease in elastic recoil force needed to drive air out of lung (“paper sack”) • Centrilobular or centriacinar form is associated with cigarette smoking • Major destruction of the acinus at the respiratory bronchiole level

  11. Panlobular or panacinar form is associated with alpha-1 antitrypsin disease • Destruction of the entire acinus • Occurs as a result of an imbalance of proteolytic enzymes in lung tissue

  12. In both forms of the disease, the cause of COPD is inflammation, both in the airways and in lung tissue

  13. Inflammation • Smoking, in • Chronic Bronchitis • Neutrophils and macrophages, lymphocytes • Emphysema • Cellular changes in terminal bronchioles • Destruction (protease enzymes) extracellular matrix of aleveoli • Ineffective repair mechanism

  14. COPD vs Asthma • Asthma • Anatomical location of inflammation • With bronchodilators and steroids, lung function returns to normal or near-normal with occasional transient inflammation • COPD • Anatomical (airways and lung parenchyma) • Some degree of irreversible deterioration

  15. Cellular differences • Asthma • Eosinophils • Mast cells • Lymphocytes • CD4 T cells

  16. Same cells: CB & Emphysema • COPD • Neturophils • Macrophages • No mast cells • CD8 T cells

  17. COPD Asthma

  18. A 20 pack year smoking history indicates that the subject’s lungs have received 20 of these short cyclic exposures per day for a cumulative total of 7300 exposures per year and 146,000 exposures over the lifetime of their smoking habit.

  19. GOLD Stages

  20. In Sum Toxic gases and particles generated in tobacco smoke come into contact with lung tissues each time a puff of smoke is inhaled Tissue injury recurs in a cyclic fashion as each cigarette is smoked

  21. Chronic Bronchitis Inflammation: mucociliary clearance disrupted epithelial barrier/defense lost increased sputum production (goblet cells) irreversible airway remodeling airflow obstruction

  22. Emphysema In lung tissue, the chronic inhalation also causes inflammation, destroys elastic recoil, disrupts balance of protective, anti-protease enzymes proteinase-antiproteniase theory elastase-antielastase “extracellular matrix”

  23. Toxins/free radicals Cigarette smoke Toxins/free radicals Stimulation of alveolar macrophages & other inflammatory cells chemotactic factors Airway inflammation Lung (pulmonary) inflammation & Injury to parenchymal cells Airflow obstruction Proteinase inhibitors (alpha1-antitrypsin) Injury to extracellular matrix Repair of extracellular matrix Chronic Bronchitis Emphysema Cough excessive sputum production dyspnea at rest

  24. Alpha1-antitrypsin • Neutrophil elastase linked to alpha-1 antitrypsin deficiency • Other cells producing proteinase enzymes: macrophages, lymphocytes—still not determined

  25. Decreased airflow resistance (airways) and decreased elastic recoil lead to: • Hyperinflation • V/Q mismatching, which further leads to decreases in Pa02, increases in PaC02 with decreased ventilation

  26. In end-stage COPD • Cor pulmonale • Pulmonary vasoconstriction (in presence of chronic low Pa02) • Increased pulmonary vascular resistance • Increased pressure, leading eventually to right heart enlargement

  27. CXR

  28. COR Pulmonale

More Related